Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 9

Results: 30

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Published in:

2013

By:

Broséus, J;
Alpermann, T;
Wulfert, M;
Florensa Brichs, L;
Jeromin, S;
Lippert, E;
Rozman, M;
Lifermann, F;
Grossmann, V;
Haferlach, T;
Germing, U;
Luño, E;
Girodon, F;
Schnittger, S;
MPN and MPNr-EuroNet (COST Action BM0902)

Publication type:

journal article

High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1933, doi. 10.1038/leu.2013.90

By:

Grossmann, V;
Schnittger, S;
Poetzinger, F;
Kohlmann, A;
Stiel, A;
Eder, C;
Fasan, A;
Kern, W;
Haferlach, T;
Haferlach, C

Publication type:

Article

Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1943, doi. 10.1038/leu.2013.179

By:

Gómez-Seguí, I;
Makishima, H;
Jerez, A;
Yoshida, K;
Przychodzen, B;
Miyano, S;
Shiraishi, Y;
Husseinzadeh, H D;
Guinta, K;
Clemente, M;
Hosono, N;
McDevitt, M A;
Moliterno, A R;
Sekeres, M A;
Ogawa, S;
Maciejewski, J P

Publication type:

Article

Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1910, doi. 10.1038/leu.2013.64

By:

Schroeder, T;
Fröbel, J;
Cadeddu, R-P;
Czibere, A;
Dienst, A;
Platzbecker, U;
Bug, G;
Uharek, L;
Fenk, R;
Germing, U;
Kröger, N;
Haas, R;
Kobbe, G

Publication type:

Article

RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1793, doi. 10.1038/leu.2013.200

By:

Koh, C P;
Wang, C Q;
Ng, C E L;
Ito, Y;
Araki, M;
Tergaonkar, V;
Huang, G;
Osato, M

Publication type:

Article

Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1913, doi. 10.1038/leu.2013.67

By:

Sun, J;
Liu, W;
Li, L;
Chen, J;
Wu, M;
Zhang, Y;
Leung, A Y H;
Zhang, W;
Wen, Z;
Liao, W

Publication type:

Article

Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1813, doi. 10.1038/leu.2013.140

By:

Platzbecker, U;
Germing, U

Publication type:

Article

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1940, doi. 10.1038/leu.2013.144

By:

Grossmann, V;
Bacher, U;
Haferlach, C;
Schnittger, S;
Pötzinger, F;
Weissmann, S;
Roller, A;
Eder, C;
Fasan, A;
Zenger, M;
Staller, M;
Kern, W;
Kohlmann, A;
Haferlach, T

Publication type:

Article

Mutations and prognosis in primary myelofibrosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1861, doi. 10.1038/leu.2013.119

By:

Vannucchi, A M;
Lasho, T L;
Guglielmelli, P;
Biamonte, F;
Pardanani, A;
Pereira, A;
Finke, C;
Score, J;
Gangat, N;
Mannarelli, C;
Ketterling, R P;
Rotunno, G;
Knudson, R A;
Susini, M C;
Laborde, R R;
Spolverini, A;
Pancrazzi, A;
Pieri, L;
Manfredini, R;
Tagliafico, E

Publication type:

Article

AKT is a therapeutic target in myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1882, doi. 10.1038/leu.2013.167

By:

Khan, I;
Huang, Z;
Wen, Q;
Stankiewicz, M J;
Gilles, L;
Goldenson, B;
Schultz, R;
Diebold, L;
Gurbuxani, S;
Finke, C M;
Lasho, T L;
Koppikar, P;
Pardanani, A;
Stein, B;
Altman, J K;
Levine, R L;
Tefferi, A;
Crispino, J D

Publication type:

Article

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1870, doi. 10.1038/leu.2013.122

By:

Pardanani, A;
Lasho, T L;
Laborde, R R;
Elliott, M;
Hanson, C A;
Knudson, R A;
Ketterling, R P;
Maxson, J E;
Tyner, J W;
Tefferi, A

Publication type:

Article

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1874, doi. 10.1038/leu.2013.163

By:

Tefferi, A;
Rumi, E;
Finazzi, G;
Gisslinger, H;
Vannucchi, A M;
Rodeghiero, F;
Randi, M L;
Vaidya, R;
Cazzola, M;
Rambaldi, A;
Gisslinger, B;
Pieri, L;
Ruggeri, M;
Bertozzi, I;
Sulai, N H;
Casetti, I;
Carobbio, A;
Jeryczynski, G;
Larson, D R;
Müllauer, L

Publication type:

Article

Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1936, doi. 10.1038/leu.2013.92

By:

Öfverholm, I;
Tran, A N;
Heyman, M;
Zachariadis, V;
Nordenskjöld, M;
Nordgren, A;
Barbany, G

Publication type:

Article

Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1920, doi. 10.1038/leu.2013.79

By:

Roschewski, M;
Farooqui, M;
Aue, G;
Wilhelm, F;
Wiestner, A

Publication type:

Article

Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1926, doi. 10.1038/leu.2013.82

By:

Takagi, M;
Piao, J;
Lin, L;
Kawaguchi, H;
Imai, C;
Ogawa, A;
Watanabe, A;
Akiyama, K;
Kobayashi, C;
Mori, M;
Ko, K;
Sugimoto, M;
Mizutani, S

Publication type:

Article

Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1930, doi. 10.1038/leu.2013.85

By:

Vorechovsky, I;
Jones, A V;
Cross, N C P

Publication type:

Article

Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1939, doi. 10.1038/leu.2013.112

By:

Tefferi, A

Publication type:

Article

Age, JAK2<sup>V617F</sup> and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1826, doi. 10.1038/leu.2013.120

By:

Broséus, J;
Alpermann, T;
Wulfert, M;
Florensa Brichs, L;
Jeromin, S;
Lippert, E;
Rozman, M;
Lifermann, F;
Grossmann, V;
Haferlach, T;
Germing, U;
Luño, E;
Girodon, F;
Schnittger, S

Publication type:

Article

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1852, doi. 10.1038/leu.2013.133

By:

Meggendorfer, M;
Bacher, U;
Alpermann, T;
Haferlach, C;
Kern, W;
Gambacorti-Passerini, C;
Haferlach, T;
Schnittger, S

Publication type:

Article

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1949, doi. 10.1038/leu.2013.190

By:

Fink, A M;
Böttcher, S;
Ritgen, M;
Fischer, K;
Pflug, N;
Eichhorst, B;
Wendtner, C-M;
Winkler, D;
Bühler, A;
Zenz, T;
Staib, P;
Mayer, J;
Hensel, M;
Hopfinger, G;
Wenger, M;
Fingerle-Rowson, G;
Döhner, H;
Kneba, M;
Stilgenbauer, S;
Busch, R

Publication type:

Article

A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1917, doi. 10.1038/leu.2013.77

By:

Mupo, A;
Celani, L;
Dovey, O;
Cooper, J L;
Grove, C;
Rad, R;
Sportoletti, P;
Falini, B;
Bradley, A;
Vassiliou, G S

Publication type:

Article

Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1803, doi. 10.1038/leu.2013.173

By:

Estey, E H

Publication type:

Article

Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1923, doi. 10.1038/leu.2013.81

By:

Aalbers, A M;
van den Heuvel-Eibrink, M M;
de Haas, V;
te Marvelde, J G;
de Jong, A X;
van der Burg, M;
Dworzak, M;
Hasle, H;
Locatelli, F;
De Moerloose, B;
Schmugge, M;
Stary, J;
Zecca, M;
Zwaan, C M;
van de Loosdrecht, A A;
van Dongen, J J M;
Niemeyer, C M;
van der Velden, V H J

Publication type:

Article

Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1841, doi. 10.1038/leu.2013.193

By:

Geyh, S;
Öz, S;
Cadeddu, R-P;
Fröbel, J;
Brückner, B;
Kündgen, A;
Fenk, R;
Bruns, I;
Zilkens, C;
Hermsen, D;
Gattermann, N;
Kobbe, G;
Germing, U;
Lyko, F;
Haas, R;
Schroeder, T

Publication type:

Article

The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1891, doi. 10.1038/leu.2013.186

By:

Allen, C;
Hills, R K;
Lamb, K;
Evans, C;
Tinsley, S;
Sellar, R;
O'Brien, M;
Yin, J L;
Burnett, A K;
Linch, D C;
Gale, R E

Publication type:

Article

Toll-like receptor alterations in myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1832, doi. 10.1038/leu.2013.180

By:

Wei, Y;
Dimicoli, S;
Bueso-Ramos, C;
Chen, R;
Yang, H;
Neuberg, D;
Pierce, S;
Jia, Y;
Zheng, H;
Wang, H;
Wang, X;
Nguyen, M;
Wang, S A;
Ebert, B;
Bejar, R;
Levine, R;
Abdel-Wahab, O;
Kleppe, M;
Ganan-Gomez, I;
Kantarjian, H

Publication type:

Article

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1902, doi. 10.1038/leu.2013.95

By:

Wang, M;
Fowler, N;
Wagner-Bartak, N;
Feng, L;
Romaguera, J;
Neelapu, S S;
Hagemeister, F;
Fanale, M;
Oki, Y;
Pro, B;
Shah, J;
Thomas, S;
Younes, A;
Hosing, C;
Zhang, L;
Newberry, K J;
Desai, M;
Cheng, N;
Badillo, M;
Bejarano, M

Publication type:

Article

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1820, doi. 10.1038/leu.2013.117

By:

Conte, N;
Varela, I;
Grove, C;
Manes, N;
Yusa, K;
Moreno, T;
Segonds-Pichon, A;
Bench, A;
Gudgin, E;
Herman, B;
Bolli, N;
Ellis, P;
Haddad, D;
Costeas, P;
Rad, R;
Scott, M;
Huntly, B;
Bradley, A;
Vassiliou, G S

Publication type:

Article

Mobilization studies in C3-deficient mice unravel the involvement of a novel crosstalk between the coagulation and complement cascades in mobilization of hematopoietic stem/progenitor cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1928, doi. 10.1038/leu.2013.84

By:

Borkowska, S;
Suszynska, M;
Wysoczynski, M;
Ratajczak, M Z

Publication type:

Article

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1946, doi. 10.1038/leu.2013.182

By:

Kosmider, O;
Itzykson, R;
Chesnais, V;
Lasho, T;
Laborde, R;
Knudson, R;
Gauthier, A;
Merlevede, J;
Ades, L;
Morabito, M;
Fontenay, M;
Tefferi, A;
Droin, N;
Solary, E

Publication type:

Article